Status:
COMPLETED
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer
Lead Sponsor:
AstraZeneca
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer
Eligibility Criteria
Inclusion
- non metastatic Prostate Cancer
- previous treatment with bicalutamide 150mg
- biochemical relapse/progression
Exclusion
- use of other treatments for Prostate Cancer
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT00668083
Start Date
September 1 2007
End Date
July 1 2008
Last Update
December 10 2010
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Acquaviva delle Fonti, Italy
2
Research Site
Ancona, Italy
3
Research SIte
Florence, Italy
4
Research Site
Matera, Italy